Annual Cost Of Goods Sold
$10.51 M
-$42.31 M-80.10%
31 December 2023
Summary:
Ligand Pharmaceuticals Incorporated annual cost of goods sold is currently $10.51 million, with the most recent change of -$42.31 million (-80.10%) on 31 December 2023. During the last 3 years, it has fallen by -$19.91 million (-65.44%). LGND annual cost of goods sold is now -83.09% below its all-time high of $62.18 million, reached on 31 December 2021.LGND Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cost Of Goods Sold
$2.45 M
-$457.00 K-15.73%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated quarterly cost of goods sold is currently $2.45 million, with the most recent change of -$457.00 thousand (-15.73%) on 30 September 2024. Over the past year, it has dropped by -$1.04 million (-29.73%). LGND quarterly cost of goods sold is now -91.99% below its all-time high of $30.59 million, reached on 30 June 2021.LGND Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Cost Of Goods Sold
$9.88 M
-$1.04 M-9.49%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated TTM cost of goods sold is currently $9.88 million, with the most recent change of -$1.04 million (-9.49%) on 30 September 2024. Over the past year, it has dropped by -$20.61 million (-67.60%). LGND TTM cost of goods sold is now -84.11% below its all-time high of $62.18 million, reached on 31 December 2021.LGND TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Cost Of Goods Sold Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -80.1% | -29.7% | -67.6% |
| 3 y3 years | -65.4% | -78.6% | -84.0% |
| 5 y5 years | +65.9% | -22.2% | -20.1% |
LGND Cost Of Goods Sold High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -83.1% | at low | -88.7% | +49.2% | -84.1% | +2.1% |
| 5 y | 5 years | -83.1% | +65.9% | -92.0% | +49.2% | -84.1% | +2.1% |
| alltime | all time | -83.1% | +207.3% | -92.0% | +127.8% | -84.1% | +184.4% |
Ligand Pharmaceuticals Incorporated Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.45 M(-15.7%) | $9.88 M(-9.5%) |
| June 2024 | - | $2.91 M(+0.8%) | $10.91 M(+12.8%) |
| Mar 2024 | - | $2.88 M(+75.6%) | $9.68 M(-7.9%) |
| Dec 2023 | $10.51 M(-80.1%) | $1.64 M(-52.9%) | $10.51 M(-65.5%) |
| Sept 2023 | - | $3.48 M(+108.8%) | $30.48 M(-25.9%) |
| June 2023 | - | $1.67 M(-55.1%) | $41.15 M(-20.6%) |
| Mar 2023 | - | $3.72 M(-82.8%) | $51.84 M(-1.9%) |
| Dec 2022 | $52.83 M(-15.0%) | $21.61 M(+52.7%) | $52.83 M(+22.3%) |
| Sept 2022 | - | $14.15 M(+14.5%) | $43.20 M(+6.7%) |
| June 2022 | - | $12.36 M(+163.1%) | $40.49 M(-31.0%) |
| Mar 2022 | - | $4.70 M(-60.8%) | $58.72 M(-5.6%) |
| Dec 2021 | $62.18 M(+104.4%) | $11.98 M(+4.7%) | $62.18 M(+0.4%) |
| Sept 2021 | - | $11.45 M(-62.6%) | $61.93 M(+9.0%) |
| June 2021 | - | $30.59 M(+275.2%) | $56.84 M(+67.7%) |
| Mar 2021 | - | $8.15 M(-30.5%) | $33.89 M(+11.4%) |
| Dec 2020 | $30.42 M(+168.1%) | $11.74 M(+84.8%) | $30.42 M(+47.5%) |
| Sept 2020 | - | $6.35 M(-16.9%) | $20.62 M(+18.4%) |
| June 2020 | - | $7.64 M(+63.2%) | $17.41 M(+43.0%) |
| Mar 2020 | - | $4.68 M(+141.8%) | $12.17 M(+7.3%) |
| Dec 2019 | $11.35 M(+79.1%) | $1.94 M(-38.4%) | $11.35 M(-8.2%) |
| Sept 2019 | - | $3.15 M(+30.9%) | $12.37 M(+15.8%) |
| June 2019 | - | $2.40 M(-37.7%) | $10.68 M(+13.5%) |
| Mar 2019 | - | $3.86 M(+30.6%) | $9.41 M(+48.4%) |
| Dec 2018 | $6.34 M(+18.1%) | $2.96 M(+102.4%) | $6.34 M(+23.8%) |
| Sept 2018 | - | $1.46 M(+28.7%) | $5.12 M(-15.3%) |
| June 2018 | - | $1.13 M(+43.9%) | $6.04 M(+4.0%) |
| Mar 2018 | - | $788.00 K(-54.7%) | $5.81 M(+8.3%) |
| Dec 2017 | $5.37 M(-3.7%) | $1.74 M(-27.1%) | $5.37 M(-17.8%) |
| Sept 2017 | - | $2.38 M(+164.1%) | $6.53 M(+27.0%) |
| June 2017 | - | $903.00 K(+164.8%) | $5.14 M(+3.7%) |
| Mar 2017 | - | $341.00 K(-88.2%) | $4.96 M(-11.0%) |
| Dec 2016 | $5.57 M(-4.1%) | $2.90 M(+190.0%) | $5.57 M(+56.6%) |
| Sept 2016 | - | $999.00 K(+38.8%) | $3.56 M(-6.6%) |
| June 2016 | - | $720.00 K(-24.6%) | $3.81 M(-33.0%) |
| Mar 2016 | - | $955.00 K(+8.0%) | $5.69 M(-2.0%) |
| Dec 2015 | $5.81 M(-36.4%) | $884.00 K(-29.3%) | $5.81 M(-34.9%) |
| Sept 2015 | - | $1.25 M(-51.9%) | $8.93 M(-2.7%) |
| June 2015 | - | $2.60 M(+142.1%) | $9.17 M(+18.2%) |
| Mar 2015 | - | $1.07 M(-73.2%) | $7.76 M(-15.1%) |
| Dec 2014 | $9.14 M(+59.4%) | $4.00 M(+167.6%) | $9.14 M(+41.7%) |
| Sept 2014 | - | $1.50 M(+26.1%) | $6.45 M(-13.9%) |
| June 2014 | - | $1.19 M(-51.6%) | $7.49 M(-0.4%) |
| Mar 2014 | - | $2.45 M(+86.2%) | $7.52 M(+31.2%) |
| Dec 2013 | $5.73 M(+59.2%) | $1.32 M(-48.1%) | $5.73 M(-15.0%) |
| Sept 2013 | - | $2.54 M(+109.1%) | $6.74 M(+38.0%) |
| June 2013 | - | $1.21 M(+83.1%) | $4.89 M(+19.0%) |
| Mar 2013 | - | $663.00 K(-71.5%) | $4.11 M(+14.1%) |
| Dec 2012 | $3.60 M | $2.33 M(+240.8%) | $3.60 M(+8.1%) |
| Sept 2012 | - | $683.00 K(+57.0%) | $3.33 M(-0.6%) |
| June 2012 | - | $435.00 K(+180.6%) | $3.35 M(-26.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $155.00 K(-92.5%) | $4.54 M(-7.5%) |
| Dec 2011 | $4.91 M(-73.1%) | $2.06 M(+192.7%) | $4.91 M(+72.2%) |
| Sept 2011 | - | $703.00 K(-56.7%) | $2.85 M(+32.7%) |
| June 2011 | - | $1.62 M(+209.1%) | $2.15 M(+309.1%) |
| Mar 2011 | - | $525.00 K(-91.8%) | $525.00 K(-97.3%) |
| Sept 2005 | - | $6.42 M(-39.8%) | $19.34 M(-14.9%) |
| June 2005 | - | $10.67 M(-3.6%) | $22.73 M(+4.4%) |
| Mar 2005 | - | $11.06 M(-225.5%) | $21.78 M(+19.3%) |
| Dec 2004 | $18.26 M(-31.2%) | -$8.82 M(-189.8%) | $18.26 M(-40.5%) |
| Sept 2004 | - | $9.82 M(+1.0%) | $30.69 M(+4.3%) |
| June 2004 | - | $9.72 M(+28.8%) | $29.43 M(+7.1%) |
| Mar 2004 | - | $7.54 M(+109.2%) | $27.48 M(+3.5%) |
| Dec 2003 | $26.56 M(+80.2%) | $3.61 M(-57.9%) | $26.56 M(+16.0%) |
| Sept 2003 | - | $8.56 M(+10.3%) | $22.90 M(+14.6%) |
| June 2003 | - | $7.77 M(+17.3%) | $19.98 M(+18.3%) |
| Mar 2003 | - | $6.62 M(<-9900.0%) | $16.90 M(+14.7%) |
| Dec 2002 | $14.74 M(+5.7%) | -$49.00 K(-100.9%) | $14.74 M(-23.1%) |
| Sept 2002 | - | $5.65 M(+20.6%) | $19.17 M(+11.7%) |
| June 2002 | - | $4.68 M(+5.0%) | $17.17 M(+17.4%) |
| Mar 2002 | - | $4.46 M(+1.7%) | $14.63 M(+21.2%) |
| Dec 2001 | $13.95 M(+62.3%) | $4.39 M(+20.3%) | $12.07 M(+21.3%) |
| Sept 2001 | - | $3.65 M(+70.3%) | $9.95 M(+16.5%) |
| June 2001 | - | $2.14 M(+12.5%) | $8.54 M(+94.8%) |
| Mar 2001 | - | $1.90 M(-15.9%) | $4.39 M(+26.5%) |
| Dec 2000 | $8.59 M(-18.1%) | $2.26 M(+1.1%) | $3.47 M(-75.4%) |
| Sept 2000 | - | $2.24 M(-211.0%) | $14.09 M(+28.6%) |
| June 2000 | - | -$2.02 M(-305.2%) | $10.96 M(-8.5%) |
| Mar 2000 | - | $983.00 K(-92.4%) | $11.97 M(+14.1%) |
| Dec 1999 | $10.49 M(-333.1%) | $12.89 M(-1532.1%) | $10.49 M(-799.3%) |
| Sept 1999 | - | -$900.00 K(-10.0%) | -$1.50 M(-37.5%) |
| June 1999 | - | -$1.00 M(+100.0%) | -$2.40 M(-25.0%) |
| Mar 1999 | - | -$500.00 K(-155.6%) | -$3.20 M(-28.9%) |
| Dec 1998 | -$4.50 M(-54.1%) | $900.00 K(-150.0%) | -$4.50 M(-44.4%) |
| Sept 1998 | - | -$1.80 M(0.0%) | -$8.10 M(-8.0%) |
| June 1998 | - | -$1.80 M(0.0%) | -$8.80 M(-5.4%) |
| Mar 1998 | - | -$1.80 M(-33.3%) | -$9.30 M(-5.1%) |
| Dec 1997 | -$9.80 M(+4.3%) | -$2.70 M(+8.0%) | -$9.80 M(+2.1%) |
| Sept 1997 | - | -$2.50 M(+8.7%) | -$9.60 M(-17.9%) |
| June 1997 | - | -$2.30 M(0.0%) | -$11.70 M(+10.4%) |
| Mar 1997 | - | -$2.30 M(-8.0%) | -$10.60 M(+12.8%) |
| Dec 1996 | -$9.40 M(+154.1%) | -$2.50 M(-45.7%) | -$9.40 M(+16.0%) |
| Sept 1996 | - | -$4.60 M(+283.3%) | -$8.10 M(+84.1%) |
| June 1996 | - | -$1.20 M(+9.1%) | -$4.40 M(+37.5%) |
| Mar 1996 | - | -$1.10 M(-8.3%) | -$3.20 M(+14.3%) |
| Dec 1995 | -$3.70 M(-115.0%) | -$1.20 M(+33.3%) | -$2.80 M(-160.9%) |
| Sept 1995 | - | -$900.00 K(+28.6%) | $4.60 M(-74.6%) |
| Mar 1995 | - | -$700.00 K(-111.3%) | $18.10 M(-26.7%) |
| Dec 1994 | $24.70 M | $6.20 M(-3.1%) | $24.70 M(+33.5%) |
| Sept 1994 | - | $6.40 M(+3.2%) | $18.50 M(+52.9%) |
| June 1994 | - | $6.20 M(+5.1%) | $12.10 M(+105.1%) |
| Mar 1994 | - | $5.90 M | $5.90 M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual cost of goods sold?
- What is the all time high annual cost of goods sold for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual cost of goods sold year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly cost of goods sold year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM cost of goods sold year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual cost of goods sold?
The current annual cost of goods sold of LGND is $10.51 M
What is the all time high annual cost of goods sold for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual cost of goods sold is $62.18 M
What is Ligand Pharmaceuticals Incorporated annual cost of goods sold year-on-year change?
Over the past year, LGND annual cost of goods sold has changed by -$42.31 M (-80.10%)
What is Ligand Pharmaceuticals Incorporated quarterly cost of goods sold?
The current quarterly cost of goods sold of LGND is $2.45 M
What is the all time high quarterly cost of goods sold for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly cost of goods sold is $30.59 M
What is Ligand Pharmaceuticals Incorporated quarterly cost of goods sold year-on-year change?
Over the past year, LGND quarterly cost of goods sold has changed by -$1.04 M (-29.73%)
What is Ligand Pharmaceuticals Incorporated TTM cost of goods sold?
The current TTM cost of goods sold of LGND is $9.88 M
What is the all time high TTM cost of goods sold for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM cost of goods sold is $62.18 M
What is Ligand Pharmaceuticals Incorporated TTM cost of goods sold year-on-year change?
Over the past year, LGND TTM cost of goods sold has changed by -$20.61 M (-67.60%)